Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Sexually Transmitted Infection | Research article

Re-emergence of syphilis in women of reproductive age and its association with the increase in congenital syphilis in Mexico during 2010–2019: an ecological study

Authors: Santa García-Cisneros, Antonia Herrera-Ortiz, Maria Olamendi-Portugal, Miguel Angel Sánchez-Alemán

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Syphilis is a sexually transmitted infection that is re-emerging in different parts of the world. This infection can be transmitted during pregnancy, causing neonatal syphilis. The objective of this study was to examine trend in syphilis, congenital syphilis, and neonatal deaths among the Mexican population during 2010–2019.

Methods

An ecological study was carried out to collect information about the incidence of syphilis, the incidence of congenital syphilis, and the incidence of neonatal death from congenital syphilis. The variables were described considering age, sex, Mexican state, and year. Trends across time (calendar year) were analyzed using linear regression, increases were estimated with 95% confidence intervals, and p < 0.05 was considered statistically significant.

Results

The incidence of syphilis increased by an average of 0.336 cases/100,000 per year and was higher among women aged 15–19 years (0.693 cases). Cases of congenital syphilis increased from 62 cases in 2010 to 372 cases in 2019; furthermore, the increase in syphilis cases among women aged 20 to 24 years was associated with an increase in cases of congenital syphilis. In 2010, 50% of Mexican states did not report cases of congenital syphilis, but in 2018, only 10% did not report cases of congenital syphilis. Between 2010 and 2018, 83 neonatal deaths were reported, with the highest incidence in 2018 (0.88 deaths/100,000 newborns).

Conclusion

The incidence of congenital syphilis is increasing in Mexico. As a consequence of the reemergence of syphilis among the population of reproductive age, it is necessary to address and treat syphilis in various population groups.
Literature
1.
go back to reference Peeling RW, Mabey D, Kamb ML, Chen XS, Radolf JD, Benzaken AS. Syphilis. Nat Rev Dis Primers. 2017;12:1–21. Peeling RW, Mabey D, Kamb ML, Chen XS, Radolf JD, Benzaken AS. Syphilis. Nat Rev Dis Primers. 2017;12:1–21.
2.
go back to reference Fonollosa A, Martinez-Indart L, Artaraz J, Martinez-Berriotxoa A, Agirrebengoa K, Garcia M, et al. Clinical manifestations and outcomes of syphilis-associated uveitis in northern Spain. Ocul Immunol Inflamm. 2016;24:147–52.PubMed Fonollosa A, Martinez-Indart L, Artaraz J, Martinez-Berriotxoa A, Agirrebengoa K, Garcia M, et al. Clinical manifestations and outcomes of syphilis-associated uveitis in northern Spain. Ocul Immunol Inflamm. 2016;24:147–52.PubMed
4.
go back to reference Corti M, Palmieri O, Maronna E. Sífilis secundaria maligna, forma clínica rupioide, en una enferma VIH positive. Rara presentación de la lúes secundaria: presentación de un caso y revisión de la literatura. Rev Argen Dermatol. 2014;95:22–6. Corti M, Palmieri O, Maronna E. Sífilis secundaria maligna, forma clínica rupioide, en una enferma VIH positive. Rara presentación de la lúes secundaria: presentación de un caso y revisión de la literatura. Rev Argen Dermatol. 2014;95:22–6.
5.
go back to reference Schmidt R, Carson PJ, Jansen RJ. Resurgence of syphilis in the United States: an assessment of contributing factors. Infect Dis. 2019;16(12):1178633719883282. Schmidt R, Carson PJ, Jansen RJ. Resurgence of syphilis in the United States: an assessment of contributing factors. Infect Dis. 2019;16(12):1178633719883282.
6.
go back to reference Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548–62.CrossRef Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548–62.CrossRef
7.
go back to reference Kamb M, Schwartz-Benzaken A, Karem K, Matheu J, Pérez F. Orientación para el diagnóstico de la sífilis en América Latina y el Caribe: cómo mejorar la adopción, interpretación y calidad del diagnóstico en diferentes entornos clínicos. Washington: OPS/OMS; 2015. p. 32. Kamb M, Schwartz-Benzaken A, Karem K, Matheu J, Pérez F. Orientación para el diagnóstico de la sífilis en América Latina y el Caribe: cómo mejorar la adopción, interpretación y calidad del diagnóstico en diferentes entornos clínicos. Washington: OPS/OMS; 2015. p. 32.
8.
go back to reference Herrera-Ortiz A, Uribe-Salas FJ, Olamendi-Portugal M, García-Cisneros S, Conde-Glez CJ, Sánchez-Alemán MA. Análisis de la tendencia de sífilis adquirida en México durante el periodo 2003–2013. Salud Publica Mex. 2015;57:335–42.CrossRef Herrera-Ortiz A, Uribe-Salas FJ, Olamendi-Portugal M, García-Cisneros S, Conde-Glez CJ, Sánchez-Alemán MA. Análisis de la tendencia de sífilis adquirida en México durante el periodo 2003–2013. Salud Publica Mex. 2015;57:335–42.CrossRef
9.
go back to reference Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LL, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Brouteta N, Taylor MM. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548–62.CrossRef Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LL, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Brouteta N, Taylor MM. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548–62.CrossRef
10.
go back to reference Spiteri G, Unemo M, Mårdh O, Amato-Gauci AJ. The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe. Epidemiol Infect. 2019;147: e143.CrossRef Spiteri G, Unemo M, Mårdh O, Amato-Gauci AJ. The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe. Epidemiol Infect. 2019;147: e143.CrossRef
11.
12.
go back to reference Organización Panamericana de la Salud. Iniciativa regional para la eliminación de la transmisión maternoinfantil de VIH y de la sífilis congénita en América Latina y el Caribe: documento conceptual. Montevideo: CLAP/SMR; 2009. Organización Panamericana de la Salud. Iniciativa regional para la eliminación de la transmisión maternoinfantil de VIH y de la sífilis congénita en América Latina y el Caribe: documento conceptual. Montevideo: CLAP/SMR; 2009.
13.
go back to reference Organización Panamericana de la Salud. ETMI-PLUS: marco para la eliminación de la transmisión maternoinfantil del VIH, la sífilis, la hepatitis y la enfermedad de Chagas. Julio del 2017. OPS/CHA/17-009. Organización Panamericana de la Salud. ETMI-PLUS: marco para la eliminación de la transmisión maternoinfantil del VIH, la sífilis, la hepatitis y la enfermedad de Chagas. Julio del 2017. OPS/CHA/17-009.
14.
go back to reference Organización Panamericana de la Salud. Eliminación de la transmisión maternoinfantil del VIH y la sífilis en las Américas. Actualización 2016. Washington, D.C.: OPS; 2017. Organización Panamericana de la Salud. Eliminación de la transmisión maternoinfantil del VIH y la sífilis en las Américas. Actualización 2016. Washington, D.C.: OPS; 2017.
15.
go back to reference Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública; 2012. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública; 2012.
16.
go back to reference Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Romero-Martínez M, Mojica-Cuevas J, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2018–19: Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública; 2020. Shamah-Levy T, Vielma-Orozco E, Heredia-Hernández O, Romero-Martínez M, Mojica-Cuevas J, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2018–19: Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública; 2020.
17.
go back to reference Herrera-Ortiz A, López-Gatell H, García-Cisneros S, Cortés-Ortiz MA, Olamendi-Portugal M, Hegewisch-Taylor J, et al. Sífilis congénita en México. Análisis de las normas nacionales e internacionales desde la perspectiva del diagnóstico de laboratorio. Gac Med Mexico. 2019;155:464–72.PubMed Herrera-Ortiz A, López-Gatell H, García-Cisneros S, Cortés-Ortiz MA, Olamendi-Portugal M, Hegewisch-Taylor J, et al. Sífilis congénita en México. Análisis de las normas nacionales e internacionales desde la perspectiva del diagnóstico de laboratorio. Gac Med Mexico. 2019;155:464–72.PubMed
18.
go back to reference Kreisel KM, Spicknall IH, Gargano JW, Lewis FM, Lewis RM, Markowitz LE, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sex Transm Dis. 2021;48:208–14.CrossRef Kreisel KM, Spicknall IH, Gargano JW, Lewis FM, Lewis RM, Markowitz LE, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sex Transm Dis. 2021;48:208–14.CrossRef
19.
20.
go back to reference Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Queen B, et al. Youth risk behavior surveillance—United States, 2017. MMWR Surveill Summ. 2018;67:1–114.CrossRef Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Queen B, et al. Youth risk behavior surveillance—United States, 2017. MMWR Surveill Summ. 2018;67:1–114.CrossRef
21.
go back to reference Aral SO. Determinants of STD epidemics: implications for phase appropriate intervention strategies. Sex Transm Infect. 2002;78(Suppl 1):i3-13.CrossRef Aral SO. Determinants of STD epidemics: implications for phase appropriate intervention strategies. Sex Transm Infect. 2002;78(Suppl 1):i3-13.CrossRef
22.
go back to reference Diez Roux AV, Aiello AE. Multilevel analysis of infectious diseases. J Infect Dis. 2005;191(Suppl 1):S25-33.CrossRef Diez Roux AV, Aiello AE. Multilevel analysis of infectious diseases. J Infect Dis. 2005;191(Suppl 1):S25-33.CrossRef
23.
go back to reference Toskin I, Bakunina N, Gerbase AC, Blondeel K, Stephenson R, Baggaley R, et al. A combination approach of behavioural and biomedical interventions for prevention of sexually transmitted infections. Bull World Health Organ. 2020;98(6):431–4.CrossRef Toskin I, Bakunina N, Gerbase AC, Blondeel K, Stephenson R, Baggaley R, et al. A combination approach of behavioural and biomedical interventions for prevention of sexually transmitted infections. Bull World Health Organ. 2020;98(6):431–4.CrossRef
24.
go back to reference Sanchez-Aleman MA, Del Villar-Tapia YG, Gutierrez JP, Garcia-Cisneros S, Olamendi-Portugal ML, Herrera-Ortiz A, et al. Heterogeneity of herpes simplex virus type 2 seroprevalence from a national probability survey in Mexico, 2012. Sex Transm Dis. 2018;45:111–7.CrossRef Sanchez-Aleman MA, Del Villar-Tapia YG, Gutierrez JP, Garcia-Cisneros S, Olamendi-Portugal ML, Herrera-Ortiz A, et al. Heterogeneity of herpes simplex virus type 2 seroprevalence from a national probability survey in Mexico, 2012. Sex Transm Dis. 2018;45:111–7.CrossRef
Metadata
Title
Re-emergence of syphilis in women of reproductive age and its association with the increase in congenital syphilis in Mexico during 2010–2019: an ecological study
Authors
Santa García-Cisneros
Antonia Herrera-Ortiz
Maria Olamendi-Portugal
Miguel Angel Sánchez-Alemán
Publication date
01-12-2021

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine